<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>4408</number>
    <updateDate>2025-10-08T03:52:51Z</updateDate>
    <updateDateIncludingText>2025-10-08T03:52:51Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2023-06-30</introducedDate>
    <congress>118</congress>
    <legislationUrl>https://www.congress.gov/bill/118th-congress/house-bill/4408</legislationUrl>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 169, Number 114 (Friday, June 30, 2023)][House]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. GALLAGHER:H.R. 4408.Congress has the power to enact this legislation pursuantto the following:The Interstate Commerce Clause: Clause 3 of Section 8 ofArticle I.The single subject of this legislation is:Pharmaceutical approval and safety[Page H3160]&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Referred to</name>
                <date>2023-07-07T19:05:01Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Unknown</name>
            <date>2023-06-30T18:08:40Z</date>
          </item>
          <item>
            <name>Referred To</name>
            <date>2023-06-30T18:08:40Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Promising Pathway Act</title>
        <congress>118</congress>
        <number>1906</number>
        <type>S</type>
        <latestAction>
          <actionDate>2023-06-08</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2023-07-07</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2023-06-30</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2023-06-30</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2023-06-30</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>G000579</bioguideId>
        <fullName>Rep. Gallagher, Mike [R-WI-8]</fullName>
        <firstName>Mike</firstName>
        <lastName>Gallagher</lastName>
        <party>R</party>
        <state>WI</state>
        <district>8</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>Q000023</bioguideId>
        <fullName>Rep. Quigley, Mike [D-IL-5]</fullName>
        <firstName>Mike</firstName>
        <lastName>Quigley</lastName>
        <party>D</party>
        <state>IL</state>
        <district>5</district>
        <sponsorshipDate>2023-06-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000821</bioguideId>
        <fullName>Rep. Westerman, Bruce [R-AR-4]</fullName>
        <firstName>Bruce</firstName>
        <lastName>Westerman</lastName>
        <party>R</party>
        <state>AR</state>
        <district>4</district>
        <sponsorshipDate>2023-06-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>S001193</bioguideId>
        <fullName>Rep. Swalwell, Eric [D-CA-14]</fullName>
        <firstName>Eric</firstName>
        <lastName>Swalwell</lastName>
        <party>D</party>
        <state>CA</state>
        <district>14</district>
        <sponsorshipDate>2023-06-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>F000466</bioguideId>
        <fullName>Rep. Fitzpatrick, Brian K. [R-PA-1]</fullName>
        <firstName>Brian</firstName>
        <lastName>Fitzpatrick</lastName>
        <party>R</party>
        <state>PA</state>
        <middleName>K.</middleName>
        <district>1</district>
        <sponsorshipDate>2023-06-30</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000632</bioguideId>
        <fullName>Rep. D'Esposito, Anthony [R-NY-4]</fullName>
        <firstName>Anthony</firstName>
        <lastName>D'Esposito</lastName>
        <party>R</party>
        <state>NY</state>
        <district>4</district>
        <sponsorshipDate>2023-08-08</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>P000616</bioguideId>
        <fullName>Rep. Phillips, Dean [D-MN-3]</fullName>
        <firstName>Dean</firstName>
        <lastName>Phillips</lastName>
        <party>D</party>
        <state>MN</state>
        <district>3</district>
        <sponsorshipDate>2023-10-26</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>W000795</bioguideId>
        <fullName>Rep. Wilson, Joe [R-SC-2]</fullName>
        <firstName>Joe</firstName>
        <lastName>Wilson</lastName>
        <party>R</party>
        <state>SC</state>
        <district>2</district>
        <sponsorshipDate>2023-12-07</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000583</bioguideId>
        <fullName>Rep. Gottheimer, Josh [D-NJ-5]</fullName>
        <firstName>Josh</firstName>
        <lastName>Gottheimer</lastName>
        <party>D</party>
        <state>NJ</state>
        <district>5</district>
        <sponsorshipDate>2023-12-07</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>F000462</bioguideId>
        <fullName>Rep. Frankel, Lois [D-FL-22]</fullName>
        <firstName>Lois</firstName>
        <lastName>Frankel</lastName>
        <party>D</party>
        <state>FL</state>
        <district>22</district>
        <sponsorshipDate>2023-12-07</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000061</bioguideId>
        <fullName>Rep. Garcia, Mike [R-CA-27]</fullName>
        <firstName>Mike</firstName>
        <lastName>Garcia</lastName>
        <party>R</party>
        <state>CA</state>
        <district>27</district>
        <sponsorshipDate>2024-04-05</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
          <updateDate>2023-11-13T13:45:34Z</updateDate>
        </item>
        <item>
          <name>Civil actions and liability</name>
          <updateDate>2023-11-13T13:45:34Z</updateDate>
        </item>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2023-11-13T13:45:34Z</updateDate>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
          <updateDate>2023-11-13T13:45:35Z</updateDate>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
          <updateDate>2023-11-13T13:45:34Z</updateDate>
        </item>
        <item>
          <name>Health information and medical records</name>
          <updateDate>2023-11-13T13:45:34Z</updateDate>
        </item>
        <item>
          <name>Prescription drugs</name>
          <updateDate>2023-11-13T13:45:34Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2023-08-03T22:30:28Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2023-06-30</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2024-06-06T19:19:31Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Promising Pathway Act&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill provides for expedited, provisional approval of drugs for serious or life-threatening diseases or conditions.&lt;/p&gt;&lt;p&gt;Specifically, the bill allows for provisional approval of drugs that are used to treat, prevent, or diagnose a serious or life-threatening disease or condition for which premature death is likely without early medical intervention. The Food and Drug Administration (FDA) must evaluate applications within 90 days of receipt. The FDA may approve applications if there is early evidence, including real-world and real-time evidence, of the drug's efficacy, as well as substantial evidence of the drug's safety. Provisional approval is valid for two years and may be renewed for up to eight years. The FDA may withdraw provisional approval in the event of serious adverse health effects.&amp;nbsp;&lt;/p&gt;&lt;p&gt;Drug sponsors that receive provisional approval must require all patients receiving the drug to participate in an observational registry, through which the drug sponsor may collect and submit data relating to the drug until it is fully approved. Registries may be operated by the drug sponsor or another entity. The FDA must annually review these registries; sponsors of registries that fail to meet the bill's requirements are subject to civil penalties.&amp;nbsp;&lt;/p&gt;&lt;p&gt;&amp;nbsp;&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Promising Pathway Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Promising Pathway Act</title>
        <updateDate>2024-06-11T15:45:56Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Promising Pathway Act</title>
        <updateDate>2024-05-24T13:38:06Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.</title>
        <updateDate>2024-03-18T21:05:48Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in House</type>
        <date>2023-06-30T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr4408ih/xml/BILLS-118hr4408ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2023-07-07</actionDate>
      <text>Referred to the Subcommittee on Health.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
